Merck KGaA

OTCPK:MKGA.F Stock Report

Market Cap: US$56.9b

Merck KGaA Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Belen Garijo Lopez

Chief executive officer

€8.3m

Total compensation

CEO salary percentage18.00%
CEO tenure11.3yrs
CEO ownershipn/a
Management average tenure7.5yrs
Board average tenure6.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Belen Garijo Lopez's remuneration changed compared to Merck KGaA's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025€8m€2m

€3b

Sep 30 2025n/an/a

€3b

Jun 30 2025n/an/a

€3b

Mar 31 2025n/an/a

€3b

Dec 31 2024€7m€2m

€3b

Sep 30 2024n/an/a

€3b

Jun 30 2024n/an/a

€3b

Mar 31 2024n/an/a

€3b

Dec 31 2023€11m€2m

€3b

Sep 30 2023n/an/a

€3b

Jun 30 2023n/an/a

€3b

Mar 31 2023n/an/a

€3b

Dec 31 2022€11m€2m

€3b

Sep 30 2022n/an/a

€3b

Jun 30 2022n/an/a

€3b

Mar 31 2022n/an/a

€3b

Dec 31 2021€9m€1m

€3b

Sep 30 2021n/an/a

€3b

Jun 30 2021n/an/a

€3b

Mar 31 2021n/an/a

€2b

Dec 31 2020€7m€1m

€2b

Sep 30 2020n/an/a

€2b

Jun 30 2020n/an/a

€1b

Mar 31 2020n/an/a

€2b

Dec 31 2019€6m€1m

€1b

Compensation vs Market: Belen's total compensation ($USD9.74M) is below average for companies of similar size in the US market ($USD14.14M).

Compensation vs Earnings: Belen's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Belen Garijo Lopez (65 yo)

11.3yrs
Tenure
€8,332,000
Compensation

Mrs. Belén Garijo López, M.D., is Chair of Executive Board and Chief Executive Officer of Merck KGaA since May 01, 2021. She served as Vice Chairman of the Executive Board and Deputy Chief Executive Office...

Leadership Team

NamePositionTenureCompensationOwnership
Belen Garijo Lopez
Chair of Executive Board & CEO11.3yrs€8.33mno data
Kai Beckmann
CEO of Electronics & Deputy Chair Executive Board15yrs€6.20mno data
Helene von Roeder
CFO & Member of Executive Board2.8yrs€4.77mno data
Danny Bar-Zohar
Member of the Executive Board & CEO of Healthcareless than a year€1.22mno data
Jean Wirth
Member of the Executive Board & CEO Life Scienceless than a year€1.21mno data
Khadija Hammada
Member of the Executive Board & Chief People Officer1.1yrs€1.21mno data
Florian Schraeder
Head of Investor Relationsno datano datano data
Axel Lober
Head of Global Communicationsno datano datano data
Frank Gotthardt
Head of Corporate & Government Relations - Europe16.8yrsno datano data
Marc Horn
Head of Life Science Controllingno datano datano data
Michael Heckmeier
Head of the Display Materials Business Unit for Performance Materials9yrsno datano data
Hans-Joachim Neumann
Head of Integrated Supply Chain7.5yrsno datano data
7.5yrs
Average Tenure
55yo
Average Age

Experienced Management: MKGA.F's management team is seasoned and experienced (7.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Dietmar Oeter
Employee Representative Member of Supervisory Board11.9yrs€80.00kno data
Alexander Putz
Employee Representative Member of Supervisory Board5.9yrs€80.00kno data
Stefan Palzer
Independent Supervisory Board Member2yrs€79.00kno data
Barbara Lambert
Independent Member of Supervisory Board2.7yrs€180.00kno data
Michael Kleinemeier
Independent Chairman of Supervisory Board7yrs€242.50kno data
Anne Lange
Vice Chairman of Supervisory Board7yrs€98.80kno data
Christian Raabe
Employee Representative Member of Supervisory Board7yrs€130.00kno data
Daniel Thelen
Independent Member of Supervisory Board7yrs€80.00kno data
Simon Thelen
Independent Member of Supervisory Board7yrs€80.00kno data
Birgit Biermann
Employee Representative Member of Supervisory Board3.8yrs€80.00kno data
Katja Vila
Independent Supervisory Board Member2yrs€130.00kno data
Michael Reinhart
Employee Representative Member of Supervisory Board2yrs€130.00kno data
6.5yrs
Average Tenure
54.5yo
Average Age

Experienced Board: MKGA.F's board of directors are considered experienced (6.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/23 02:34
End of Day Share Price 2026/04/23 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Merck KGaA is covered by 40 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Odile RundquistBaader Helvea Equity Research
Gerhard SchwarzBaader Helvea Equity Research
Emily FieldBarclays